Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...

Through the use of preoperative axillary ultrasound (AUS), more patients with clinical node‑positive (cNI) breast cancer and ...

Please provide your email address to receive an email when new articles are posted on . Similar proportions of older women with node-negative and node-positive early breast cancer had Oncotype Dx ...

The practice of selectively removing a few lymph nodes, instead of removing all axillary, or armpit, lymph nodes, is still relatively new. The number of women who undergo sentinel lymph node biopsy ...

Applies to most patients with one or two positive sentinel lymph nodes ...

Omitting sentinel lymph node biopsy (SLNB) in patients with early-stage breast cancer undergoing breast-conserving surgery may not increase the risk for recurrence over 5 years, according to findings ...

10-year outcomes of breast cancer patients with histologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy. This is an ASCO Meeting ...

Prognostic value of mitosis-specific antibodies and computer image analysis in calculating mitotic rate in melanoma. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract ...

Positive lymph node status is not a reliable indicator of the need for adjunctive chemotherapy, and sentinel node biopsy may not be helpful in older women with certain low-risk breast cancers, ...

Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...

Future breast cancer treatment options may not only increase patients’ survival but also reduce or eliminate their need for surgery altogether, says breast cancer surgeon Sara Javid, MD, Fred ...